Generic multi-step therapeutic treatment protocol
US6579280B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Apr 30, 1999 |
| Grant date | Jun 17, 2003 |
| Priority date | — |
| Expiry date | Nov 15, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/3605
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A generic treatment protocol is disclosed for therapeutically treating a patient via an implantable treatment device. Treatment steps can be defined to start and end at absolute times, or can be programmed via telemetry to start a certain amount of time after termination of a previously executed treatment step. Treatment steps have a treatment rate or dose attribute and a duration attribute. Treatment steps may optionally enable patient-activated bolus overlays. Patient-activated rate or dosage adjustments can also optionally be enabled. Repeated-execution treatment-step groups are also provided. Such treatment-step groups can have start and end times, a group duration, and a group total dose, each defined in a manner similar to that for a treatment step. Treatment-step groups include a repetition count, which could be set to a value that causes the group to repeat forever. Single execution treatment steps can, accordingly, be programmed to execute before and/or after a repeated-execution treatment-step group.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.